Edit Content

Iran Faces Soaring Medicine Prices Amid Growing Health Crisis

Iran's medicine prices skyrocket up to 400%, exposing a regime-induced crisis hurting ordinary citizens while funding regional terror proxies.

25/03/2025

People queuing outside a pharmacy at night.

A severe rise in medicine prices across Iran has sparked growing concern among pharmacists, doctors, and the general public, as access to life-saving medications becomes increasingly unaffordable. Reports from inside the country, including regime-affiliated news agency “Mehr,” indicate drug prices have surged between 50% and 400% in recent weeks, intensifying the already dire humanitarian and economic situation.

The Iranian regime blames internal disruptions within the country’s pharmaceutical industry for the crisis, pointing to breakdowns in the supply chain. However, top Iranian health officials are contradicting the regime’s narrative, suggesting the real cause is far more systemic—and deliberate.

Akbar Abdollahi Asl, the director of Iran’s Drug and Controlled Substances Division, claims the country’s healthcare system has monopolized the pharmaceutical industry. According to him, the very entity responsible for regulating drug prices is also the main buyer and policymaker—creating a dangerous conflict of interest.

He further alleged that there is a conscious effort by the regime to shrink the pharmaceutical sector using restrictive pricing and production quotas. “They’re leaving a narrow path for the industry to survive, while limiting it as much as possible. This is intentional, not accidental,” Asl stated.

Critics argue this manufactured scarcity serves a sinister fiscal agenda: create shortages, then charge a captive population—especially the ill and elderly—exorbitant prices to manage the regime’s ballooning deficit. It’s an economic strategy that comes at the expense of Iran’s most vulnerable citizens.

The skyrocketing medicine prices are yet another symptom of a collapsing regime that prioritizes ideological hegemony and foreign terror proxies over the basic needs of its own people. As Tehran pours billions into Hamas, Hezbollah, and the Houthis, Iranians are being left to choose between hunger and healthcare.

What’s unfolding is not just a public health emergency—it’s a moral failure, and a stark indictment of a regime that is losing legitimacy by the day.

Related Articles

Two men in suits discussing in a formal room.
Trump proposes U.S. control of Gaza, calling it a “good thing” to replace terror with stability, security, and prosperity.
Two men in suits discussing in a formal room.
Trump exposed Hamas’ brutality through hostages’ testimony—no mercy, no compassion, only beatings—proving again who the real enemy is.
Two men in suits discussing in a formal room.
In the Oval Office, Trump reaffirmed unwavering U.S. support for Israel, praising Netanyahu and vowing unity against Iran’s threats.
Two men in suits discussing in a formal room.
In the Oval Office, Trump rebuffed misleading narratives on Gaza, affirming the war will end only with terror’s defeat.
Two men in suits discussing in a formal room.
In the Oval Office, Secretary Hegseth vowed harsh retaliation against the Houthis, signaling a new phase in U.S. strategy.
Two men in suits discussing in a formal room.
In a powerful Oval Office moment, Trump and Netanyahu issued a final warning to Iran: peace or devastating consequences await.
Two men in suits discussing in a formal room.
Trump's upcoming Iran talks could reshape the region—Israel’s future hinges on whether diplomacy fails or emboldens the world's most dangerous terror regime.
Iranian and Saudi leaders in official attire
In a rare call, Iran’s president and Saudi Arabia’s crown prince discussed Gaza, regional stability, and Iran’s nuclear intentions.
No More Articles